Camurus is a Swedish science-led pharmaceutical company committed to developing and commercialising innovative and long-acting medicines for the treatment of severe and chronic diseases.
We focus on diseases of the central nervous system, rare diseases, endocrine disorders, oncology and supportive care. FluidCrystal is Camurus’ patent-protected technology that, when combined with active pharmaceutical compounds with established efficacy and safety characteristics or new chemical entities, offers the promise of improvements in treatment outcomes, convenience and quality of life for people with serious and chronic diseases whilst also having the potential to improve the utilisation of resources in the healthcare system.
